19-7633434-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_174895.3(PCP2):​c.24G>A​(p.Thr8Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.341 in 1,575,464 control chromosomes in the GnomAD database, including 94,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 7063 hom., cov: 33)
Exomes 𝑓: 0.35 ( 87663 hom. )

Consequence

PCP2
NM_174895.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0410

Publications

14 publications found
Variant links:
Genes affected
PCP2 (HGNC:30209): (Purkinje cell protein 2) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of catalytic activity. Predicted to act upstream of or within rhodopsin mediated signaling pathway. Predicted to be located in neuronal cell body. [provided by Alliance of Genome Resources, Apr 2022]
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 19-7633434-C-T is Benign according to our data. Variant chr19-7633434-C-T is described in ClinVar as Benign. ClinVar VariationId is 403501.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.041 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.363 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCP2NM_174895.3 linkc.24G>A p.Thr8Thr synonymous_variant Exon 1 of 4 ENST00000311069.6 NP_777555.1
PCP2XM_024451346.2 linkc.187G>A p.Gly63Arg missense_variant Exon 1 of 5 XP_024307114.1
STXBP2NM_001414484.1 linkc.-60+2588C>T intron_variant Intron 3 of 20 NP_001401413.1
PCP2XM_006722639.4 linkc.-60-604G>A intron_variant Intron 1 of 3 XP_006722702.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCP2ENST00000311069.6 linkc.24G>A p.Thr8Thr synonymous_variant Exon 1 of 4 1 NM_174895.3 ENSP00000310585.4
ENSG00000268400ENST00000698368.1 linkn.114+2775C>T intron_variant Intron 2 of 19 ENSP00000513686.1

Frequencies

GnomAD3 genomes
AF:
0.290
AC:
44039
AN:
151720
Hom.:
7056
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.209
Gnomad AMR
AF:
0.245
Gnomad ASJ
AF:
0.270
Gnomad EAS
AF:
0.195
Gnomad SAS
AF:
0.290
Gnomad FIN
AF:
0.417
Gnomad MID
AF:
0.290
Gnomad NFE
AF:
0.367
Gnomad OTH
AF:
0.298
GnomAD2 exomes
AF:
0.297
AC:
55860
AN:
187902
AF XY:
0.304
show subpopulations
Gnomad AFR exome
AF:
0.158
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.259
Gnomad EAS exome
AF:
0.182
Gnomad FIN exome
AF:
0.413
Gnomad NFE exome
AF:
0.360
Gnomad OTH exome
AF:
0.330
GnomAD4 exome
AF:
0.346
AC:
492828
AN:
1423624
Hom.:
87663
Cov.:
39
AF XY:
0.345
AC XY:
243371
AN XY:
704550
show subpopulations
African (AFR)
AF:
0.156
AC:
5143
AN:
32890
American (AMR)
AF:
0.197
AC:
7740
AN:
39206
Ashkenazi Jewish (ASJ)
AF:
0.266
AC:
6755
AN:
25386
East Asian (EAS)
AF:
0.190
AC:
7280
AN:
38268
South Asian (SAS)
AF:
0.288
AC:
23401
AN:
81240
European-Finnish (FIN)
AF:
0.408
AC:
20686
AN:
50678
Middle Eastern (MID)
AF:
0.291
AC:
1661
AN:
5712
European-Non Finnish (NFE)
AF:
0.367
AC:
400926
AN:
1091348
Other (OTH)
AF:
0.327
AC:
19236
AN:
58896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
16024
32047
48071
64094
80118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12586
25172
37758
50344
62930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.290
AC:
44059
AN:
151840
Hom.:
7063
Cov.:
33
AF XY:
0.290
AC XY:
21564
AN XY:
74236
show subpopulations
African (AFR)
AF:
0.164
AC:
6772
AN:
41388
American (AMR)
AF:
0.245
AC:
3746
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.270
AC:
936
AN:
3464
East Asian (EAS)
AF:
0.195
AC:
1006
AN:
5150
South Asian (SAS)
AF:
0.290
AC:
1396
AN:
4814
European-Finnish (FIN)
AF:
0.417
AC:
4411
AN:
10568
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.367
AC:
24879
AN:
67872
Other (OTH)
AF:
0.302
AC:
636
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1566
3131
4697
6262
7828
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.331
Hom.:
17195
Bravo
AF:
0.269
Asia WGS
AF:
0.250
AC:
873
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
3.2
DANN
Benign
0.61
PhyloP100
0.041
PromoterAI
-0.0080
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1862514; hg19: chr19-7698320; COSMIC: COSV55403018; COSMIC: COSV55403018; API